دورية أكاديمية

Stability Study of 0.5 g/mL Urea Oral Solution in InOrpha®

التفاصيل البيبلوغرافية
العنوان: Stability Study of 0.5 g/mL Urea Oral Solution in InOrpha®
المؤلفون: Bourbon Johan, Dory Anne, Perello Laurent, Belotti Laure, Reisz Fanny, Ubeaud-Sequier Genevieve, Gourieux Bénédicte
المصدر: Pharmaceutical Technology in Hospital Pharmacy, Vol 4, Iss 2, Pp 69-76 (2019)
بيانات النشر: De Gruyter, 2019.
سنة النشر: 2019
المجموعة: LCC:Therapeutics. Pharmacology
LCC:Pharmaceutical industry
مصطلحات موضوعية: urea, hyponatremia, oral liquid solution, stability, hplc, uv-detection, Therapeutics. Pharmacology, RM1-950, Pharmaceutical industry, HD9665-9675
الوصف: Urea is recommended in the 2nd line treatment in moderate to severe hyponatraemia induced by syndrome of inappropriate antidiuretic hormone secretion (SIADH), when water restriction is insufficient. A posology of 0.25–0.5 g/kg daily is suggested. A usual but inadequate urea oral preparation, i. e. 10 g urea powder dissolved in 100 mL water before use, was classically compounded. Therefore the pharmacy has developed a 0.5 g/mL urea oral liquid solution in InOrpha® with better organoleptic characteristics to improve treatment adherence and reduce the preparation time. The aim of this study was to determine physicochemical and microbiological stability of the urea oral liquid solution in order to establish a shelf life of the preparation.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2365-2411
2365-242X
العلاقة: https://doaj.org/toc/2365-2411Test; https://doaj.org/toc/2365-242XTest
DOI: 10.1515/pthp-2019-0015
الوصول الحر: https://doaj.org/article/159e74e9b9fe42b8b9fd463eef813ce4Test
رقم الانضمام: edsdoj.159e74e9b9fe42b8b9fd463eef813ce4
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:23652411
2365242X
DOI:10.1515/pthp-2019-0015